Abstract
Variant ataxia telangiectasia (A-T) may be an underdiagnosed entity. We correlate data from radiosensitivity and kinase assays with clinical and molecular data from a patient with variant A-T and relatives. The coding region of ATM was sequenced. To evaluate the functional effect of the mutations, we performed kinase assays and developed a novel S-G2 micronucleus test. Our patient presented with mild dystonia, moderately dysarthric speech, increased serum α-fetoprotein but no ataxia nor telangiectasias, no nystagmus or oculomotor dyspraxia. She has a severe IgA deficiency, but does not have recurrent infections. She is compound heterozygote for ATM c.8122G>A (p.Asp2708Asn) and c.8851-1G>T, leading to in frame loss of 63 nucleotides at the cDNA level. A trace amount of ATM protein is translated from both alleles. Residual kinase activity is derived only from the p.Asp2708Asn allele. The conventional G0 micronucleus test, based on irradiation of resting lymphocytes, revealed a radiosensitive phenotype for the patient, but not for the heterozygous relatives. As ATM is involved in homologous recombination and G2/M cell cycle checkpoint, we optimized an S-G2 micronucleus assay, allowing to evaluate micronuclei in lymphocytes irradiated in the S and G2 phases. This test showed increased radiosensitivity for both the patient and the heterozygous carriers. Intriguingly, heterozygous carriers of c.8851-1G>T (mutation associated with absence of kinase activity) showed a stronger radiosensitive phenotype with this assay than heterozygous carriers of p.Asp2708Asn (mutation associated with residual kinase activity). The modified S-G2 micronucleus assay provided phenotypic insight into complement the diagnosis of this atypical A-T patient.
Similar content being viewed by others
References
Angele, S., Romestaing, P., Moullan, N., Vuillaume, M., Chapot, B., Friesen, M., et al. (2003). ATM haplotypes and cellular response to DNA damage: Association with breast cancer risk and clinical radiosensitivity. Cancer Research, 63(24), 8717–8725.
Bakkenist, C. J., & Kastan, M. B. (2003). DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature, 421(6922), 499–506. doi:10.1038/nature01368.
Baria, K., Warren, C., Roberts, S. A., West, C. M., & Scott, D. (2001). Chromosomal radiosensitivity as a marker of predisposition to common cancers? British Journal of Cancer, 84(7), 892–896. doi:10.1054/bjoc.2000.1701.
Barone, G., Groom, A., Reiman, A., Srinivasan, V., Byrd, P. J., & Taylor, A. M. (2009). Modeling ATM mutant proteins from missense changes confirms retained kinase activity. Human Mutation, 30(8), 1222–1230. doi:10.1002/humu.21034.
Bartsch, O., Schindler, D., Beyer, V., Gesk, S., van’t Slot, R., Feddersen, I., et al. (2012). A girl with an atypical form of ataxia telangiectasia and an additional de novo 3.14 Mb microduplication in region 19q12. European journal of medical genetics, 55(1), 49–55. doi:10.1016/j.ejmg.2011.08.001.
Beamish, H., & Lavin, M. F. (1994). Radiosensitivity in ataxia-telangiectasia: Anomalies in radiation-induced cell cycle delay. International Journal of Radiation Biology, 65(2), 175–184.
Bernstein, J. L., Haile, R. W., Stovall, M., Boice, J. D, Jr, Shore, R. E., Langholz, B., et al. (2010). Radiation exposure, the ATM Gene, and contralateral breast cancer in the women’s environmental cancer and radiation epidemiology study. Journal of the National Cancer Institute, 102(7), 475–483. doi:10.1093/jnci/djq055.
Buck, D., Moshous, D., de Chasseval, R., Ma, Y., le Deist, F., Cavazzana-Calvo, M., et al. (2006). Severe combined immunodeficiency and microcephaly in siblings with hypomorphic mutations in DNA ligase IV. European Journal of Immunology, 36(1), 224–235. doi:10.1002/eji.200535401.
Cavalieri, S., Funaro, A., Porcedda, P., Turinetto, V., Migone, N., Gatti, R. A., et al. (2006). ATM mutations in Italian families with ataxia telangiectasia include two distinct large genomic deletions. Human Mutation, 27(10), 1061. doi:10.1002/humu.9454.
Chen, P., Farrell, A., Hobson, K., Girjes, A., & Lavin, M. (1994). Comparative study of radiation-induced G2 phase delay and chromatid damage in families with ataxia-telangiectasia. Cancer Genetics and Cytogenetics, 76(1), 43–46.
Chen, P. C., Lavin, M. F., Kidson, C., & Moss, D. (1978). Identification of ataxia telangiectasia heterozygotes, a cancer prone population. Nature, 274(5670), 484–486.
Deckbar, D., Birraux, J., Krempler, A., Tchouandong, L., Beucher, A., Walker, S., et al. (2007). Chromosome breakage after G2 checkpoint release. Journal of Cell Biology, 176(6), 749–755. doi:10.1083/jcb.200612047.
Fernet, M., Moullan, N., Lauge, A., Stoppa-Lyonnet, D., & Hall, J. (2004). Cellular responses to ionising radiation of AT heterozygotes: Differences between missense and truncating mutation carriers. British Journal of Cancer, 90(4), 866–873. doi:10.1038/sj.bjc.6601549.
Gennery, A. R. (2006). Primary immunodeficiency syndromes associated with defective DNA double-strand break repair. British Medical Bulletin, 77–78, 71–85. doi:10.1093/bmb/ldl006.
Gilad, S., Chessa, L., Khosravi, R., Russell, P., Galanty, Y., Piane, M., et al. (1998). Genotype-phenotype relationships in ataxia-telangiectasia and variants. American Journal of Human Genetics, 62(3), 551–561. doi:10.1086/301755.
Girard, P. M., Foray, N., Stumm, M., Waugh, A., Riballo, E., Maser, R. S., et al. (2000). Radiosensitivity in Nijmegen Breakage Syndrome cells is attributable to a repair defect and not cell cycle checkpoint defects. Cancer Research, 60(17), 4881–4888.
Goldgar, D. E., Healey, S., Dowty, J. G., Da Silva, L., Chen, X., Spurdle, A. B., et al. (2011). Rare variants in the ATM gene and risk of breast cancer. Breast Cancer Research, 13(4), R73. doi:10.1186/bcr2919.
Hiel, J. A., van Engelen, B. G., Weemaes, C. M., Broeks, A., Verrips, A., ter Laak, H., et al. (2006). Distal spinal muscular atrophy as a major feature in adult-onset ataxia telangiectasia. Neurology, 67(2), 346–349. doi:10.1212/01.wnl.0000224878.22821.23.
Jacquemin, V., Rieunier, G., Jacob, S., Bellanger, D., d’Enghien, C. D., Lauge, A., et al. (2012). Underexpression and abnormal localization of ATM products in ataxia telangiectasia patients bearing ATM missense mutations. European Journal of Human Genetics, 20(3), 305–312. doi:10.1038/ejhg.2011.196.
Jongmans, W., Vuillaume, M., Kleijer, W. J., Lakin, N. D., & Hall, J. (1998). The p53-mediated DNA damage response to ionizing radiation in fibroblasts from ataxia-without-telangiectasia patients. International Journal of Radiation Biology, 74(3), 287–295.
Khalil, H. S., Tummala, H., & Zhelev, N. (2012). ATM in focus: A damage sensor and cancer target. Biodiscovery, 5(1), 1–60. doi:10.7750/BioDiscovery.2012.5.1.
Kozlov, S. V., Graham, M. E., Jakob, B., Tobias, F., Kijas, A. W., Tanuji, M., et al. (2011). Autophosphorylation and ATM activation: Additional sites add to the complexity. Journal of Biological Chemistry, 286(11), 9107–9119. doi:10.1074/jbc.M110.204065.
Kozlov, S. V., Graham, M. E., Peng, C., Chen, P., Robinson, P. J., & Lavin, M. F. (2006). Involvement of novel autophosphorylation sites in ATM activation. EMBO Journal, 25(15), 3504–3514. doi:10.1038/sj.emboj.7601231.
Kuhne, M., Riballo, E., Rief, N., Rothkamm, K., Jeggo, P. A., & Lobrich, M. (2004). A double-strand break repair defect in ATM-deficient cells contributes to radiosensitivity. Cancer Research, 64(2), 500–508.
Kurz, E. U., & Lees-Miller, S. P. (2004). DNA damage-induced activation of ATM and ATM-dependent signaling pathways. DNA Repair (Amst), 3(8–9), 889–900. doi:10.1016/j.dnarep.2004.03.029.
Lavin, M. F. (2008). Ataxia-telangiectasia: From a rare disorder to a paradigm for cell signalling and cancer. Nature Reviews Molecular Cell Biology, 9(10), 759–769. doi:10.1038/nrm2514.
Meyer, A., John, E., Dork, T., Sohn, C., Karstens, J. H., & Bremer, M. (2004). Breast cancer in female carriers of ATM gene alterations: Outcome of adjuvant radiotherapy. Radiotherapy and Oncology, 72(3), 319–323. doi:10.1016/j.radonc.2004.07.010.
Pantelias, G. E., & Terzoudi, G. I. (2011). A standardized G2-assay for the prediction of individual radiosensitivity. Radiotherapy and Oncology, 101(1), 28–34. doi:10.1016/j.radonc.2011.09.021.
Parshad, R., & Sanford, K. K. (2001). Radiation-induced chromatid breaks and deficient DNA repair in cancer predisposition. Critical Reviews in Oncology Hematology, 37(2), 87–96.
Prodosmo, A., De Amicis, A., Nistico, C., Gabriele, M., Di Rocco, G., Monteonofrio, L., et al. (2013). p53 centrosomal localization diagnoses ataxia-telangiectasia homozygotes and heterozygotes. The Journal of clinical investigation, 123(3), 1335–1342. doi:10.1172/JCI67289.
Reiman, A., Srinivasan, V., Barone, G., Last, J. I., Wootton, L. L., Davies, E. G., et al. (2011). Lymphoid tumours and breast cancer in ataxia telangiectasia; substantial protective effect of residual ATM kinase activity against childhood tumours. British Journal of Cancer, 105(4), 586–591. doi:10.1038/bjc.2011.266.
Riballo, E., Kuhne, M., Rief, N., Doherty, A., Smith, G. C., Recio, M. J., et al. (2004). A pathway of double-strand break rejoining dependent upon ATM, Artemis, and proteins locating to gamma-H2AX foci. Molecular Cell, 16(5), 715–724. doi:10.1016/j.molcel.2004.10.029.
Sanford, K. K., Parshad, R., Price, F. M., Jones, G. M., Tarone, R. E., Eierman, L., et al. (1990). Enhanced chromatid damage in blood lymphocytes after G2 phase x irradiation, a marker of the ataxia-telangiectasia gene. Journal of the National Cancer Institute, 82(12), 1050–1054.
Saviozzi, S., Saluto, A., Taylor, A. M., Last, J. I., Trebini, F., Paradiso, M. C., et al. (2002). A late onset variant of ataxia-telangiectasia with a compound heterozygous genotype, A8030G/7481insA. Journal of Medical Genetics, 39(1), 57–61.
Scott, D., Barber, J. B., Spreadborough, A. R., Burrill, W., & Roberts, S. A. (1999). Increased chromosomal radiosensitivity in breast cancer patients: A comparison of two assays. International Journal of Radiation Biology, 75(1), 1–10.
Scott, D., Spreadborough, A. R., Jones, L. A., Roberts, S. A., & Moore, C. J. (1996). Chromosomal radiosensitivity in G2-phase lymphocytes as an indicator of cancer predisposition. Radiation Research, 145(1), 3–16.
Silvestri, G., Masciullo, M., Piane, M., Savio, C., Modoni, A., Santoro, M., et al. (2010). Homozygosity for c 6325T > G transition in the ATM gene causes an atypical, late-onset variant form of ataxia-telangiectasia. Journal of Neurology, 257(10), 1738–1740. doi:10.1007/s00415-010-5583-7.
Simonin, C., Devos, D., Vuillaume, I., de Martinville, B., Sablonniere, B., Destee, A., et al. (2008). Attenuated presentation of ataxia-telangiectasia with familial cancer history. Journal of Neurology, 255(8), 1261–1263. doi:10.1007/s00415-008-0857-z.
Stankovic, T., Kidd, A. M., Sutcliffe, A., McGuire, G. M., Robinson, P., Weber, P., et al. (1998). ATM mutations and phenotypes in ataxia-telangiectasia families in the British Isles: Expression of mutant ATM and the risk of leukemia, lymphoma, and breast cancer. American Journal of Human Genetics, 62(2), 334–345. doi:10.1086/301706.
Stray-Pedersen, A., Borresen-Dale, A. L., Paus, E., Lindman, C. R., Burgers, T., & Abrahamsen, T. G. (2007). Alpha fetoprotein is increasing with age in ataxia-telangiectasia. European journal of paediatric neurology, 11(6), 375–380. doi:10.1016/j.ejpn.2007.04.001.
Sun, X., Becker-Catania, S. G., Chun, H. H., Hwang, M. J., Huo, Y., Wang, Z., et al. (2002). Early diagnosis of ataxia-telangiectasia using radiosensitivity testing. Journal of Pediatrics, 140(6), 724–731. doi:10.1067/mpd.2002.123879.
Sutton, I. J., Last, J. I., Ritchie, S. J., Harrington, H. J., Byrd, P. J., & Taylor, A. M. (2004). Adult-onset ataxia telangiectasia due to ATM 5762ins137 mutation homozygosity. Annals of neurology, 55(6), 891–895. doi:10.1002/ana.20139.
Tavtigian, S. V., Oefner, P. J., Babikyan, D., Hartmann, A., Healey, S., Le Calvez-Kelm, F., et al. (2009). Rare, evolutionarily unlikely missense substitutions in ATM confer increased risk of breast cancer. American Journal of Human Genetics, 85(4), 427–446. doi:10.1016/j.ajhg.2009.08.018.
Tchirkov, A., Bay, J. O., Pernin, D., Bignon, Y. J., Rio, P., Grancho, M., et al. (1997). Detection of heterozygous carriers of the ataxia-telangiectasia (ATM) gene by G2 phase chromosomal radiosensitivity of peripheral blood lymphocytes. Human Genetics, 101(3), 312–316.
Terzoudi, G. I., Hatzi, V. I., Barszczewska, K., Manola, K. N., Stavropoulou, C., Angelakis, P., et al. (2009). G2-checkpoint abrogation in irradiated lymphocytes: A new cytogenetic approach to assess individual radiosensitivity and predisposition to cancer. International Journal of Oncology, 35(5), 1223–1230.
Uziel, T., Savitsky, K., Platzer, M., Ziv, Y., Helbitz, T., Nehls, M., et al. (1996). Genomic organization of the ATM gene. Genomics, 33(2), 317–320. doi:10.1006/geno.1996.0201.
Verhagen, M. M., Abdo, W. F., Willemsen, M. A., Hogervorst, F. B., Smeets, D. F., Hiel, J. A., et al. (2009). Clinical spectrum of ataxia-telangiectasia in adulthood. Neurology, 73(6), 430–437. doi:10.1212/WNL.0b013e3181af33bd.
Verhagen, M. M., Last, J. I., Hogervorst, F. B., Smeets, D. F., Roeleveld, N., Verheijen, F., et al. (2012). Presence of ATM protein and residual kinase activity correlates with the phenotype in ataxia-telangiectasia: A genotype-phenotype study. Human Mutation, 33(3), 561–571. doi:10.1002/humu.22016.
Vral, A., Thierens, H., & De Ridder, L. (1996). Micronucleus induction by 60Co gamma-rays and fast neutrons in ataxia telangiectasia lymphocytes. International Journal of Radiation Biology, 70(2), 171–176.
Wang, H., Boecker, W., Wang, H., Wang, X., Guan, J., Thompson, L. H., et al. (2004). Caffeine inhibits homology-directed repair of I-SceI-induced DNA double-strand breaks. Oncogene, 23(3), 824–834. doi:10.1038/sj.onc.1207168.
West, C. M., Elyan, S. A., Berry, P., Cowan, R., & Scott, D. (1995). A comparison of the radiosensitivity of lymphocytes from normal donors, cancer patients, individuals with ataxia-telangiectasia (A-T) and A-T heterozygotes. International Journal of Radiation Biology, 68(2), 197–203.
Willems, P., August, L., Slabbert, J., Romm, H., Oestreicher, U., Thierens, H., et al. (2010). Automated micronucleus (MN) scoring for population triage in case of large scale radiation events. International Journal of Radiation Biology, 86(1), 2–11. doi:10.3109/09553000903264481.
Xu, B., Kim, S. T., Lim, D. S., & Kastan, M. B. (2002). Two molecularly distinct G(2)/M checkpoints are induced by ionizing irradiation. Molecular and Cellular Biology, 22(4), 1049–1059.
Zhang, P., Bhakta, K. S., Puri, P. L., Newbury, R. O., Feramisco, J. R., & Wang, J. Y. (2003). Association of ataxia telangiectasia mutated (ATM) gene mutation/deletion with rhabdomyosarcoma. Cancer Biology and Therapy, 2(1), 87–91.
Acknowledgments
This research was supported by grant G.A044.10 from the Fund for Scientific Research Flanders (FWO) to KC, “Emmanuel van der Schueren” grant from the “Vlaamse Liga tegen Kanker” to PS and by the “VLIR Own Initiative Programme” ZEIN2011PR387 between Belgium and South Africa. Bruce Poppe is a senior clinical investigator for the Fund for Scientific Research Flanders (FWO). We would like to thank Mijke Verhagen for her helpful advices. AMRT thanks Cancer Research UK for continued support.
Author information
Authors and Affiliations
Corresponding author
Additional information
K. Claes, J. Depuydt, M. D’Hooghe and A. Vral contributed equally to this work.
Rights and permissions
About this article
Cite this article
Claes, K., Depuydt, J., Taylor, A.M.R. et al. Variant Ataxia Telangiectasia: Clinical and Molecular Findings and Evaluation of Radiosensitive Phenotypes in a Patient and Relatives. Neuromol Med 15, 447–457 (2013). https://doi.org/10.1007/s12017-013-8231-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12017-013-8231-4